Welcome to our dedicated page for Silicon Labs SEC filings (Ticker: SLAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Silicon Laboratories Inc. (Silicon Labs, NASDAQ: SLAB) SEC filings, offering investors and analysts a primary view into the company’s regulatory disclosures. As a public semiconductor company focused on low-power wireless connectivity and embedded technology, Silicon Labs uses filings such as Forms 10-K, 10-Q, and 8-K to report its financial condition, risk factors, and material events.
In recent Form 8-K filings, Silicon Labs has reported quarterly results and explained its use of non-GAAP financial measures alongside GAAP metrics. These disclosures describe how the company adjusts for items like stock compensation expense, intangible asset amortization, acquisition- and disposition-related items, termination costs and impairments, equity-method investment adjustments, certain interest expense items, and income tax adjustments based on a long-term non-GAAP tax rate. The reconciliations included in these filings help readers understand the relationship between GAAP and non-GAAP results.
Through this SEC filings page, users can review annual reports (Form 10-K) for comprehensive discussions of Silicon Labs’ business, markets, and risks, and quarterly reports (Form 10-Q) for interim financial updates. Current reports (Form 8-K) provide timely information on earnings releases and other material developments. Where applicable, insider transaction reports (Form 4) can be used to track equity transactions by directors and officers.
Stock Titan enhances access to these documents with AI-powered summaries that highlight key sections, explain complex accounting or tax adjustments, and surface important changes across reporting periods. Real-time updates from EDGAR ensure that new Silicon Labs filings appear promptly, helping users quickly locate the information most relevant to their analysis of SLAB stock and the company’s financial reporting practices.
Wyatt Christy reported acquisition or exercise transactions in this Form 4 filing.
SILICON LABORATORIES INC. director Christy Wyatt received a grant of 962 restricted stock units (RSUs), each representing one share of common stock. After this award, Wyatt directly holds 9,454 common shares. The RSUs will fully vest on the earlier of the first anniversary of the grant date or one day before the next year’s Annual Meeting of Stockholders.
Silicon Laboratories Inc. director Navdeep S. Sooch received an equity grant through restricted stock units. The award covers 1,226 RSUs, each convertible into one share of common stock. All RSUs vest on the earlier of the first anniversary of the grant date or one day before the next year’s Annual Meeting of Stockholders. After this grant, Sooch directly holds 401,502 shares of Silicon Laboratories common stock, showing this is a routine compensation-related acquisition rather than an open-market purchase.
Sadana Sumit reported acquisition or exercise transactions in this Form 4 filing.
SILICON LABORATORIES INC. director Sumit Sadana received a grant of 962 restricted stock units (RSUs) of common stock at no cash cost. Each RSU represents the right to receive one share of common stock.
The RSUs will vest in full on the earlier of the first anniversary of the grant date or one day before the company’s next Annual Meeting of Stockholders. After this award, Sadana directly holds 9,982 shares of Silicon Labs common stock, reflecting a modest, compensation-related increase in his equity stake.
Richardson Nina reported acquisition or exercise transactions in this Form 4 filing.
Silicon Laboratories Inc. director Nina Richardson received a grant of 962 restricted stock units (RSUs) of common stock. The RSUs entitle her to one share of common stock for each unit, at no purchase price.
The RSUs will vest in full on the earlier of the first anniversary of the grant date or one day before the company’s next Annual Meeting of Stockholders in the following year. After this compensation-related award, Richardson holds 9,505 shares of Silicon Laboratories common stock directly.
BOCK WILLIAM G reported acquisition or exercise transactions in this Form 4 filing.
Silicon Laboratories Inc. director William G. Bock reported an equity compensation grant. He received 962 shares of common stock in the form of restricted stock units on April 23, 2026, at a stated price of $0.00 per share.
Each RSU entitles him to one share of common stock. The RSUs will vest in full on the earlier of the first anniversary of the grant date or one day prior to the company’s next Annual Meeting of Stockholders following the grant. After this award, Bock directly holds 33,920 shares of common stock.
LOWE GREGG A reported acquisition or exercise transactions in this Form 4 filing.
SILICON LABORATORIES INC. director Gregg A. Lowe received a grant of 962 restricted stock units (RSUs), each representing one share of common stock. The RSUs vest in full on the earlier of the first anniversary of the grant date or one day before the next Annual Meeting of Stockholders. Following this award, Lowe directly holds 14,956 shares of common stock.
Luther Sherri R reported acquisition or exercise transactions in this Form 4 filing.
Silicon Laboratories Inc. director Sherri R. Luther received an equity award in the form of restricted stock units. The grant covers 962 RSUs, each convertible into one share of common stock. These RSUs vest in full on the earlier of the first anniversary of the grant date or the day before the next year’s Annual Meeting of Stockholders.
After this award, Luther directly holds 6,701 shares of Silicon Labs common stock. This is a compensation-related grant, not an open-market stock purchase or sale.
Silicon Laboratories Inc. held its Annual Meeting of Stockholders on April 23, 2026. Stockholders elected Class I directors Navdeep S. Sooch and Nina Richardson, each receiving over 26.8 million votes in favor with relatively low opposition and abstentions.
Stockholders also ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending January 2, 2027, with over 29.3 million votes for the proposal. In advisory voting, stockholders approved executive compensation and separately approved amendments to the Company’s 2009 Stock Incentive Plan.
Silicon Laboratories Inc. is asking stockholders to approve a merger with Texas Instruments. If approved, Merger Sub will merge into Silicon Labs and Silicon Labs will become a wholly owned subsidiary of Texas Instruments.
Each outstanding share of Silicon Labs common stock will convert into the right to receive $231.00 in cash, less applicable withholding. The Board unanimously recommends that stockholders vote FOR the Merger Proposal, the Compensation Proposal and the Adjournment Proposal. The Special Meeting is scheduled for April 30, 2026 and the Record Date was March 23, 2026 (32,968,416 shares outstanding as of that date).
Silicon Laboratories Inc Schedule 13G/A: The Vanguard Group filed an amendment reporting zero shares beneficially owned and 0% of Silicon Laboratories Inc common stock. The filing explains an internal realignment effective January 12, 2026 under SEC Release No. 34-39538 that caused certain Vanguard subsidiaries and business divisions to report holdings separately.
The form states Vanguard's subsidiaries continue the same investment strategies previously pursued and that The Vanguard Group, Inc. no longer is deemed to have beneficial ownership of securities held by those entities.